View More Recent Stories
-
Ashland (ASH) completes sale of nutraceuticals business
-
Ashland Inc. (ASH) PT Lowered to $92 at BMO Capital
-
JPMorgan Upgrades Ashland Inc. (ASH) to Neutral
-
Ashland Inc. (ASH) PT Lowered to $110 at Wolfe Research
-
Ashland (ASH) Tops Q3 EPS by 4c; offers guidance
-
10 policies if Trump wins and stock implications: Jefferies

